(0.11%) 5 254.35 points
(0.12%) 39 807 points
(-0.12%) 16 379 points
(-0.07%) $83.11
(-0.62%) $1.752
(0.73%) $2 254.80
(0.74%) $25.10
(1.45%) $922.85
(0.35%) $0.927
(0.79%) $10.85
(0.11%) $0.792
(0.16%) $92.59
Quarter results today
(bmo 2024-03-28)
Expected move: +/- 13.55%
@ $8.00
Issued: 14 Feb 2024 @ 09:30
Return: 66.50%
Previous signal: Feb 13 - 09:30
Previous signal:
Return: 4.30 %
Live Chart Being Loaded With Signals
Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles; and SGT-003, a ext-generation gene transfer candidate for the treatment of duchenne muscular dystrophy...
Stats | |
---|---|
Today's Volume | 817 874 |
Average Volume | 354 736 |
Market Cap | 502.92M |
EPS | $-1.050 ( 2023-11-08 ) |
Next earnings date | ( $-0.570 ) 2024-05-09 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -2.76 |
ATR14 | $0.0530 (0.40%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-02-13 | Hanrahan Jessie | Buy | 65 000 | Employee Stock Option (Right to Buy) |
2024-02-13 | Hanrahan Jessie | Buy | 32 500 | Restricted Stock Units |
2024-02-13 | Cumbo Alexander | Buy | 240 250 | Employee Stock Option (Right to Buy) |
2024-02-13 | Cumbo Alexander | Buy | 120 125 | Restricted Stock Units |
2024-02-13 | Brooks Gabriel | Buy | 87 500 | Employee Stock Option (Right to Buy) |
INSIDER POWER |
---|
95.53 |
Last 96 transactions |
Buy: 8 087 237 | Sell: 205 981 |
Volume Correlation
Solid Biosciences Inc Correlation
10 Most Positive Correlations | |
---|---|
CIZN | 0.814 |
10 Most Negative Correlations | |
---|---|
CATB | -0.823 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Solid Biosciences Inc Correlation - Currency/Commodity
Solid Biosciences Inc Financials
Annual | 2023 |
Revenue: | $0 |
Gross Profit: | $-2.58M (0.00 %) |
EPS: | $-4.83 |
Q4 | 2023 |
Revenue: | $0 |
Gross Profit: | $-587 000 (0.00 %) |
EPS: | $-1.000 |
Q3 | 2023 |
Revenue: | $0 |
Gross Profit: | $-588 000 (0.00 %) |
EPS: | $-1.050 |
Q2 | 2023 |
Revenue: | $0 |
Gross Profit: | $-703 000 (0.00 %) |
EPS: | $-1.250 |
Financial Reports:
No articles found.
Solid Biosciences Inc
Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles; and SGT-003, a ext-generation gene transfer candidate for the treatment of duchenne muscular dystrophy. It also engages in developing of platform technologies, including dual gene expression, a technology for packaging multiple transgenes into one vector, as well as novel capsids. The company has collaboration and license agreement with Ultragenyx Pharmaceutical Inc. to develop and commercialize new gene therapies for Duchenne Muscular Dystrophy. Solid Biosciences Inc. was incorporated in 2013 and is headquartered in Cambridge, Massachusetts.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators